|
Experimental Models for Testing Novel Targets for Pancreatic Cancer Cell Invasion
|
5R21CA124931-02
|
$200,970
|
$200,970
|
MOUSA, SHAKER
|
ALBANY COLLEGE OF PHARMACY
|
|
Core Support for Cancer Center
|
5P30CA013330-37
|
$3,927,232
|
$39,272
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
RTOG Tissue Bank
|
5U24CA114734-05
|
$808,869
|
$80,887
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Molecular Target Focused Discovery of Anticancer Drugs
|
5R01CA090441-07
|
$381,250
|
$53,375
|
PETTIT, GEORGE
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Image-Guided System for Cancer Intervention
|
5R42CA115112-03
|
$158,937
|
$158,937
|
Vosburgh, Kirby
|
ASCENSION TECHNOLOGY CORPORATION
|
|
CellWell?: A microdevice for single cell analysis
|
5R21CA133551-03
|
$140,625
|
$140,625
|
NETTIKADAN, SAJU
|
ASPERA CORPORATION
|
|
Novel human anti-uPAR antibodies for the treatment of pancreatic cancer
|
1R43CA137884-01A1
|
$158,025
|
$158,025
|
FAN, XIAOMIN
|
AVANTGEN, INC.
|
|
PDX-1 is a Therapeutic Target for Pancreatic Cancer
|
5R01CA095731-07
|
$274,814
|
$274,814
|
BRUNICARDI, FRANCIS
|
BAYLOR COLLEGE OF MEDICINE
|
|
Roles of Zinc Transporter ZIP4 (SLC39A4) in Pancreatic Cancer Pathogenesis
|
1R21CA133604-01A2
|
$168,850
|
$168,850
|
LI, MIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S1
|
$117,279
|
$7,037
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S2
|
$245,600
|
$14,736
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-03
|
$1,515,000
|
$90,900
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pharmacological Impact of 3-Dimensional Extracellular Matrix on Tumor Cells
|
1R43CA141913-01
|
$198,120
|
$198,120
|
HAYES, STEVEN
|
BELLBROOK LABS, LLC
|
|
The role of endothelial to mesenchymal transition (EndMT) in the tumor stroma
|
5K08CA129204-02
|
$135,270
|
$67,635
|
ZEISBERG, ELISABETH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Metabolic Syndrome as Pancreatic Cancer Etiology
|
5R21CA127794-02
|
$229,500
|
$229,500
|
ZHOU, JIN-RONG
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Case-only Cancer Clustering for Mobile Populations
|
2R44CA135818-02
|
$433,039
|
$433,039
|
Jacquez, Geoffrey
|
BIOMEDWARE
|
|
Cancer Cluster Morphology
|
5R44CA112743-03
|
$374,582
|
$262,207
|
Jacquez, Geoffrey
|
BIOMEDWARE
|
|
Inducing Chromosomal Damage Responses in Pancreatic Cancer
|
1R21CA133654-01A2
|
$178,750
|
$178,750
|
Faller, Douglas
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
NADPH oxidase and pancreatic cancer cell survival
|
5R01CA119025-04
|
$72,009
|
$72,009
|
GUKOVSKAYA, ANNA
|
BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
|
|
Biomarkers and Therapeutic Targets in Pancreatic Cancer
|
5R01CA114103-05
|
$287,037
|
$287,037
|
WHANG, EDWARD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Mitochondrial DNA Mutations in Pancreatic Cancer
|
1R21CA133080-01A1
|
$248,462
|
$248,462
|
Tranah, Gregory
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
|
5U01CA062502-16
|
$772,307
|
$7,723
|
DOWLATI, AFSHIN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-20S2
|
$70,196
|
$702
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-20S3
|
$99,890
|
$999
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-20
|
$4,865,452
|
$48,655
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Normal Cellular Prion Protein in Pancreatic Cancer
|
5R21CA133559-02
|
$141,300
|
$141,300
|
SY, MAN-SUN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Research and Mentoring on Energetic Factors and Cancer: Established Investigator
|
1K05CA136967-01A1
|
$131,592
|
$6,580
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CXCL12/CXCR4 Signaling - A Novel Target for Pancreatic Intraepithelial Neoplasia
|
1K22CA134637-01A2
|
$191,700
|
$191,700
|
KIM, JOSEPH
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Transforming growth factor beta signaling pathways
|
5R01CA055536-18
|
$308,158
|
$77,040
|
HOWE, PHILIP
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
An integrative approach to cancer gene discovery in hepatocellular carcinoma
|
5R01CA124648-03
|
$429,479
|
$42,948
|
POWERS, SCOTT
|
COLD SPRING HARBOR LABORATORY
|
|
Cancer Center Clinical Trials Reporting Program (CTRP) Early Adopters
|
3P30CA013696-36S1
|
$99,928
|
$999
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-36
|
$3,999,822
|
$39,998
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
PTEN Tumor Suppressor and Signal Transduction
|
5R01CA082783-09
|
$241,297
|
$120,649
|
Parsons, Ramon
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Mouse Model for Human Pancreatic Ductal Adenocarcinoma
|
2R56CA109525-06
|
|
$0
|
SU, GLORIA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The tumor-suppressive role of ALK4/ACVR1B in pancreatic tumorigenesis
|
5R21CA127701-02
|
$181,125
|
$181,125
|
SU, GLORIA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Role of Inflammation and Stroma in Digestive Cancer
|
3U54CA126513-04S1
|
$59,906
|
$3,594
|
Wang, Timothy
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Role of Inflammation and Stroma in Digestive Cancer
|
5U54CA126513-04
|
$1,377,742
|
$82,665
|
Wang, Timothy
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Detection and Diagnosis of Pancreatic Cancer
|
2R56CA096924-05
|
|
$0
|
GOLD, DAVID
|
CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY
|
|
Chemotherapy of Pancreatic Cancer: Induction of Apoptosis or Senescence
|
5R21CA123313-02
|
$208,238
|
$208,238
|
MODRAK, DAVID
|
CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
$3,736
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
$3,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
$4,301
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
$350,667
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Genetics and Biology of Pancreatic Duct Adenocarcinoma
|
5P01CA117969-04
|
$1,838,383
|
$1,838,383
|
DePinho, Ronald
|
DANA-FARBER CANCER INSTITUTE
|
|
DF/HCC SPORE in Gastrointestinal Cancer
|
5P50CA127003-03
|
$2,300,001
|
$920,000
|
FUCHS, CHARLES
|
DANA-FARBER CANCER INSTITUTE
|
|
Technology for sensitive and reliable mutational profiling in pancreatic cancer
|
1R21CA138280-01
|
$227,040
|
$227,040
|
Makrigiorgos, G.
|
DANA-FARBER CANCER INSTITUTE
|
|
Cohort Study of Biochemical and Genetic Risk Factors for Pancreatic Cancer
|
1K07CA140790-01
|
$177,777
|
$177,777
|
WOLPIN, BRIAN
|
DANA-FARBER CANCER INSTITUTE
|
|
Role of microRNAs in genetic mouse models of pancreatic cancer
|
1R21CA135664-01A1
|
$243,448
|
$243,448
|
KORC, MURRAY
|
DARTMOUTH COLLEGE
|
|
Dysregulation of TGF Beta Action Pancreatic Cancer
|
3R37CA075059-11S1
|
$103,558
|
$103,558
|
KORC, MURRAY
|
DARTMOUTH COLLEGE
|
|
microRNAs as novel Biomarkers for Pancreatic Ductal Adenocarcinoma
|
5R21CA133715-02
|
$143,910
|
$143,910
|
KORC, MURRAY
|
DARTMOUTH COLLEGE
|
Total relevant funding to Pancreas for this search: $89,726,841
|